HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial

Vulvar intraepithelial neoplasia: Risk factors for recurrence

(2018) W. Satmary et al.   GYNECOLOGIC ONCOLOGY

CD4 + T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness

(2017) Tomasz Ahrends et al.   IMMUNITY

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

(2016) M. I. E. van Poelgeest et al.   CLINICAL CANCER RESEARCH

Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions

(2015) Beatriz Serrano et al.   EUROPEAN JOURNAL OF CANCER

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

(2015) Cornelia L Trimble et al.   LANCET

Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia

(2013) Mathias K. Fehr et al.   Journal of Gynecologic Oncology

Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer

(2012) S. Tan et al.   CURRENT CANCER DRUG TARGETS

Vulvar intraepithelial neoplasia (VIN 2/3): Comparing clinical outcomes and evaluating risk factors for recurrence

(2012) J.J. Wallbillich et al.   GYNECOLOGIC ONCOLOGY

Rational Design of DNA Vaccines for the Induction of Human Papillomavirus Type 16 E6- and E7-Specific Cytotoxic T-Cell Responses

(2012) Koen Oosterhuis et al.   HUMAN GENE THERAPY

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

(2010) S Daayana et al.   BRITISH JOURNAL OF CANCER

More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia

(2009) M Mahto et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

(2009) Gemma G. Kenter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Surgery followed by Persistence of High-Grade Squamous Intraepithelial Lesions Is Associated with the Induction of a Dysfunctional HPV16-Specific T-Cell Response

(2008) P. J. de Vos van Steenwijk et al.   CLINICAL CANCER RESEARCH

GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial

(2008) S.G.L. Quaak et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis

(2008) Hugo De Vuyst et al.   INTERNATIONAL JOURNAL OF CANCER

DNA vaccines: ready for prime time?

(2008) Michele A. Kutzler et al.   NATURE REVIEWS GENETICS

Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod

(2008) Manon van Seters et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates

(2008) Babs E. Verstrepen et al.   VACCINE